MENU
+Compare
PEN
Stock ticker: NYSE
AS OF
Oct 17 closing price
Price
$249.00
Change
-$4.84 (-1.91%)
Capitalization
9.71B

PEN Penumbra Forecast, Technical & Fundamental Analysis

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots... Show more

PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PEN with price predictions
Oct 17, 2025

PEN in downward trend: price dove below 50-day moving average on October 13, 2025

PEN moved below its 50-day moving average on October 13, 2025 date and that indicates a change from an upward trend to a downward trend. In of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where PEN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on October 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PEN as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PEN turned negative on October 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for PEN crossed bearishly below the 50-day moving average on September 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PEN broke above its upper Bollinger Band on October 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PEN entered a downward trend on October 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEN advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PEN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.508) is normal, around the industry mean (61.545). P/E Ratio (65.873) is within average values for comparable stocks, (37.720). Projected Growth (PEG Ratio) (0.589) is also within normal values, averaging (1.699). PEN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (7.680) is also within normal values, averaging (79.818).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PEN is expected to report earnings to rise 7.78% to 92 cents per share on November 05

Penumbra PEN Stock Earnings Reports
Q3'25
Est.
$0.93
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.16
The last earnings report on July 29 showed earnings per share of 86 cents, beating the estimate of 82 cents. With 337.47K shares outstanding, the current market capitalization sits at 9.71B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical devices

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Penumbra Place
Phone
+1 510 748-3200
Employees
4200
Web
https://www.penumbrainc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ADBG9.670.23
+2.44%
Leverage Shares 2X Long ADBE Daily ETF
HRTS32.260.10
+0.33%
Tema Heart & Health ETF
BKUI49.90N/A
N/A
BNY Mellon Ultra Short Income ETF
CHAT63.00-0.58
-0.91%
Roundhill Generative AI & Technology ETF
XRPI13.75-0.15
-1.08%
XRP ETF

PEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PEN has been loosely correlated with BSX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PEN jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-1.91%
BSX - PEN
44%
Loosely correlated
+1.49%
PODD - PEN
43%
Loosely correlated
+0.73%
ISRG - PEN
42%
Loosely correlated
+2.65%
ITGR - PEN
38%
Loosely correlated
+1.66%
SYK - PEN
37%
Loosely correlated
+1.40%
More

Groups containing PEN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PEN
1D Price
Change %
PEN100%
-1.91%
Medical/Nursing Services
industry (219 stocks)
54%
Loosely correlated
-0.92%
Health Services
industry (427 stocks)
5%
Poorly correlated
-1.10%